nifedipine has been researched along with iloprost in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (28.00) | 18.7374 |
| 1990's | 8 (32.00) | 18.2507 |
| 2000's | 4 (16.00) | 29.6817 |
| 2010's | 5 (20.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bakmiwewa, SM; Ball, HJ; Fatokun, AA; Hunt, NH; Payne, RJ; Tran, A | 1 |
| Cooke, ED; Nicolaides, AN | 1 |
| Boxer, LA; Ljungman, AG; Marks, RM; Morganroth, ML; Riva, CM; Schoeneich, SO; Todd, RF; Ward, PA | 1 |
| Belcher, G; Watson, HR | 1 |
| Belch, JJ; Forbes, CD; O'Dowd, A; Sturrock, RD | 1 |
| Ioannou, P; Talesnik, J | 1 |
| Müller, B; Schmidtke, M | 1 |
| Müller, B; Schmidtke, M; Witt, W | 1 |
| Tiegs, G; Wendel, A; Wolter, M | 1 |
| Almond, NE; Beacham, JA; Cooke, ED; Kirby, JD; Mant, TG; Rademaker, M; Smith, RE | 1 |
| Demĭrel, E; Türker, RK | 1 |
| Barth, HL; Hempelmann, RG; Mehdorn, HM; Pradel, RH; Ziegler, A | 1 |
| Gross, JS; Shua-Haim, JR | 1 |
| Bazzi, S; Berruti, V; Castagnone, D; Mascagni, B; Quarto di Palo, F; Rivolta, R; Scorza, R | 1 |
| Brennecke, SP; Coleman, HA; Davies, NK; Parkington, HC; Tonta, MA | 1 |
| Ghofrani, HA; Grimminger, F; Olschewski, H; Schermuly, R; Seeger, W; Temmesfeld-Wollbruck, B; Walmrath, D | 1 |
| Kaiukov, AV; Kokorin, KV; Konychev, AV; Koreshkina, TA | 1 |
| Ewert, R; Felix, S; Opitz, C; Schlag, K; Wensel, R | 1 |
| Kayikçioğlu, M; Kültürsay, H | 1 |
| Girndt, M; Herink, AK; Keysser, G; Köthe, L | 1 |
| Araújo, AC; Jorge, VC; Noronha, C; Panarra, A; Riso, N; Vaz Riscado, M | 1 |
| Atay, S; Campochiaro, C; Clark, KEN; Denton, CP; Ong, V | 1 |
| Abignano, G; Lettieri, G; Mennillo, GA | 1 |
3 review(s) available for nifedipine and iloprost
| Article | Year |
|---|---|
Raynaud's syndrome.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Epoprostenol; Female; Humans; Iloprost; Moxisylyte; Nifedipine; Raynaud Disease | 1990 |
[Raynaud's phenomenon: clinical aspects of the disease].
Topics: Calcium Channel Blockers; Cold Temperature; Diagnosis, Differential; Female; Humans; Iloprost; Male; Nifedipine; Plasmapheresis; Raynaud Disease; Risk Factors; Sensitivity and Specificity; Sex Factors; Vasodilator Agents | 2001 |
[Current approach to the treatment of pulmonary arterial hypertension and our experience in the Cardiology Department of Medicine Faculty of Ege University].
Topics: Antihypertensive Agents; Diltiazem; Disease Progression; Epoprostenol; Humans; Hypertension, Pulmonary; Iloprost; Nifedipine; Turkey; Vasodilator Agents | 2009 |
3 trial(s) available for nifedipine and iloprost
| Article | Year |
|---|---|
Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
Topics: Administration, Oral; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Epoprostenol; Female; Hemodynamics; Humans; Iloprost; Infusions, Intravenous; Male; Nifedipine; Random Allocation; Raynaud Disease; Regional Blood Flow; Scleroderma, Systemic | 1989 |
Effect of iloprost infusion on the resistance index of renal vessels of patients with systemic sclerosis.
Topics: Brachial Artery; Female; Humans; Iloprost; Kidney Cortex; Middle Aged; Nifedipine; Prospective Studies; Renal Circulation; Scleroderma, Systemic; Ultrasonography, Doppler, Color; Vascular Resistance | 1997 |
Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
Topics: Administration, Inhalation; Adult; Aged; Atrial Function, Right; Calcium Channel Blockers; Drug Therapy, Combination; Epoprostenol; Female; Heart Failure; Humans; Hypertension, Pulmonary; Iloprost; Infusions, Intravenous; Lung; Male; Middle Aged; Nifedipine; Nitric Oxide; Pulmonary Fibrosis; Pulmonary Gas Exchange; Pulmonary Wedge Pressure; Vascular Resistance; Vasodilator Agents; Ventilation-Perfusion Ratio; Vital Capacity | 1999 |
19 other study(ies) available for nifedipine and iloprost
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; HEK293 Cells; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Substrate Specificity | 2012 |
Iloprost inhibits neutrophil-induced lung injury and neutrophil adherence to endothelial monolayers.
Topics: 1-Methyl-3-isobutylxanthine; Adenine; Adenylyl Cyclase Inhibitors; Animals; Cell Adhesion; Cyclic AMP; Iloprost; In Vitro Techniques; Macrophage-1 Antigen; Male; Neutrophils; Nifedipine; Permeability; Phosphodiesterase Inhibitors; Rats; Respiratory Distress Syndrome; Superoxides; Tetradecanoylphorbol Acetate | 1990 |
Retrospective comparison of iloprost with other treatments for secondary Raynaud's phenomenon.
Topics: Connective Tissue Diseases; Humans; Iloprost; Infusions, Intravenous; Nifedipine; Raynaud Disease; Retrospective Studies | 1991 |
Platelet sensitivity to a prostacyclin analogue in systemic sclerosis.
Topics: Adult; Dinoprostone; Dose-Response Relationship, Drug; Epoprostenol; Humans; Iloprost; Middle Aged; Nifedipine; Platelet Aggregation; Prostaglandins E, Synthetic; Prostaglandins, Synthetic; Raynaud Disease; Scleroderma, Systemic | 1985 |
Platelet antiaggregatory substances inhibit arachidonic acid induced coronary constriction.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Arachidonic Acid; Arachidonic Acids; Cardiovascular Agents; Coronary Circulation; Dipyridamole; Epoprostenol; Guinea Pigs; Heart; Hydralazine; Iloprost; In Vitro Techniques; Male; Nifedipine; Perfusion; Platelet Aggregation; Rats; Rats, Inbred Strains; Vasoconstriction | 1986 |
Microvascular effects of iloprost in the hamster cheek pouch.
Topics: Alprostadil; Animals; Capillary Permeability; Cheek; Cricetinae; Epoprostenol; Iloprost; Male; Mesocricetus; Microcirculation; Nifedipine; Vasodilation | 1987 |
Action of the stable prostacyclin analogue iloprost on microvascular tone and -permeability in the hamster cheek pouch.
Topics: Alprostadil; Animals; Blood Pressure; Capillary Permeability; Cricetinae; Dose-Response Relationship, Drug; Epoprostenol; Iloprost; Male; Mesocricetus; Microcirculation; Mouth Mucosa; Muscle Tonus; Nifedipine; Permeability; Platelet Aggregation; SRS-A | 1987 |
Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice.
Topics: Allopurinol; Animals; Chemical and Drug Induced Liver Injury; Eicosanoic Acids; Endotoxins; Epoprostenol; Galactosamine; Iloprost; Imidazoles; Male; Mice; Mice, Inbred Strains; Nifedipine; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Verapamil; Xanthine Oxidase | 1989 |
Possible calcium channel modulating activity of iloprost in rabbit isolated vascular segments.
Topics: Animals; Calcium Channels; Epoprostenol; Female; Iloprost; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Potassium Chloride; Rabbits | 1989 |
Effects of potassium channel openers in isolated human cerebral arteries.
Topics: Benzopyrans; Calcium Channel Blockers; Carbachol; Cerebral Arteries; Cromakalim; Culture Techniques; Dose-Response Relationship, Drug; Endothelium, Vascular; Guanidines; Humans; Iloprost; Nifedipine; Nimodipine; Pinacidil; Potassium Channels; Pyrroles; Vasodilator Agents | 1995 |
Geriatrics photo quiz. Raynaud's: classic "blue fingertips'.
Topics: Adult; Aged; Calcium Channel Blockers; Diagnosis, Differential; Female; Humans; Iloprost; Male; Middle Aged; Nifedipine; Raynaud Disease; Sympathectomy; Vasodilator Agents | 1996 |
Hyperpolarization and slowing of the rate of contraction in human uterus in pregnancy by prostaglandins E2 and f2alpha: involvement of the Na+ pump.
Topics: Albuterol; Calcium; Calcium Channel Blockers; Charybdotoxin; Cyclic AMP; Dinoprost; Dinoprostone; Enzyme Inhibitors; Female; Glyburide; Humans; Hypoglycemic Agents; Iloprost; Membrane Potentials; Myometrium; Nifedipine; Ouabain; Potassium; Potassium Channel Blockers; Potassium Channels; Pregnancy; Sodium-Potassium-Exchanging ATPase; Sympathomimetics; Tetraethylammonium; Uterine Contraction; Vasodilator Agents | 1999 |
[Pulmonary hypertension in hereditary haemorrhagic teleangiectasia (Rendu-Osler-Weber disease). Progression over 10 years].
Topics: Anticoagulants; Antihypertensive Agents; Bosentan; Calcium Channel Blockers; Diuretics; Endothelin Receptor Antagonists; Epistaxis; Epoprostenol; Female; Furosemide; Humans; Hypertension, Pulmonary; Iloprost; Middle Aged; Nifedipine; Pedigree; Phenprocoumon; Pyridines; Sulfonamides; Telangiectasia, Hereditary Hemorrhagic; Treatment Failure; Vasodilator Agents | 2005 |
[Treatment options of acral ulcers in MCTD].
Topics: Adult; Amides; Analgesia, Patient-Controlled; Angiography, Digital Subtraction; Autonomic Nerve Block; Azathioprine; Combined Modality Therapy; Drug Therapy, Combination; Female; Fingers; Humans; Hyperbaric Oxygenation; Iloprost; Infusions, Intravenous; Mixed Connective Tissue Disease; Nifedipine; Prednisolone; Raynaud Disease; Ropivacaine; Skin Ulcer; Vasodilator Agents | 2010 |
Buerger's disease (Thromboangiitis obliterans): a diagnostic challenge.
Topics: Adult; Angiography; Aspirin; Atorvastatin; Calcium Channel Blockers; Drug Therapy, Combination; Heparin, Low-Molecular-Weight; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iloprost; Male; Nifedipine; Pentoxifylline; Platelet Aggregation Inhibitors; Pyrroles; Smoking Cessation; Thromboangiitis Obliterans | 2011 |
Autoimmunity and immunodeficiency at the crossroad: autoimmune disorders as the presenting feature of selective IgM deficiency.
Topics: Adult; Aftercare; Antirheumatic Agents; Autoimmune Diseases; Humans; Hydroxychloroquine; Iloprost; Immunoglobulin G; Immunoglobulin M; Immunologic Deficiency Syndromes; Infusions, Intravenous; Male; Mixed Connective Tissue Disease; Myalgia; Nifedipine; Synovitis; Treatment Outcome; Vasodilator Agents | 2019 |
Foot ulcers in systemic sclerosis escape surgical amputation.
Topics: Aged; Analgesics, Opioid; Anti-Bacterial Agents; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Foot Ulcer; Humans; Iloprost; Naloxone; Nifedipine; Oxycodone; Rivaroxaban; Scleroderma, Systemic; Vasodilator Agents | 2020 |